Additional studies indicated that current clinical treatment utilizing statins to target hypercholesterolemia has impacted Rac activity in a manner that alters the composition of atherosclerotic plaque beyond simply modulating cholesterol synthesis. Here, AKT1 is linked to familial hypercholesterolemia.